GLP-1-Based Therapeutics Summit
Evvnt Promotion / evvnt
15.05.2024 - 16.05.2024 Hilton Philadelphia City Avenue, 4200 City Avenue, 19131 Philadelphia, Pennsylvania, USA
Time: 7:45 AM - 4:15 PM
Kongressthemen
Welcome to the Inaugural GLP-1-Based Therapeutics Summit! - Elucidate Strategies for Product Specialization and Indication Expansion through Pharmacoeconomic Analysis
Grab your copy of the Full Agenda: https://ter.li/jphri4
Amidst the resounding success of Novo's SELECT trial, the clinical trial landscape finds itself inundated with a surge of innovative GLP-1 treatments.
Welcome to the Inaugural GLP-1-Based Therapeutics Summit! - Elucidate Strategies for Product Specialization and Indication Expansion through Pharmacoeconomic Analysis
Grab your copy of the Full Agenda: https://ter.li/jphri4
Amidst the resounding success of Novo's SELECT trial, the clinical trial landscape finds itself inundated with a surge of innovative GLP-1 treatments.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2215794-3?pid=4832
Speakers: Andrew Young - Chief Medical Officer - i2o Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2215794-3?pid=4832
Speakers: Andrew Young - Chief Medical Officer - i2o Therapeutics, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2215794-2?pid=4832
Frau Kelly Cassidy
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
Drug Developer Pricing | Conference Only: USD 2999.00, Academic Pricing | Conference Only : USD 2599.00, Standard Pricing | Conference Only: USD 3699.00
Drug Developer Pricing | Conference Only: USD 2999.00, Academic Pricing | Conference Only : USD 2599.00, Standard Pricing | Conference Only: USD 3699.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
